Rezultati pretrage - Leiblein, Sabine

  • Prikaz rezultata 1 – 5 od 5
Detaljiziraj rezultate
  1. 1
    Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR)

    Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR) od Weber, Axel, Taube, Sylvia, zur Stadt, Udo, Horstmann, Martin, Krohn, Knut, Bradtke, Jutta, Teigler-Schlegel, Andrea, Leiblein, Sabine, Christiansen, Holger

    Izdano 2012
    Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
    Tekst
    Spremi u popis
    Spremljeno u:
  2. 2
    Highly Elevated Serum Hepcidin in Patients with Acute Myeloid Leukemia prior to and after Allogeneic Hematopoietic Cell Transplantation: Does This Protect from Excessive Parenchymal Iron Loading?

    Highly Elevated Serum Hepcidin in Patients with Acute Myeloid Leukemia prior to and after Allogeneic Hematopoietic Cell Transplantation: Does This Protect from Excessive Parenchyma... od Eisfeld, Ann-Kathrin, Westerman, Mark, Krahl, Rainer, Leiblein, Sabine, Liebert, Uwe Gerd, Hehme, Marianne, Teupser, Daniel, Niederwieser, Dietger, Al-Ali, Haifa Kathrin

    Izdano 2011
    Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
    Tekst
    Spremi u popis
    Spremljeno u:
  3. 3
    Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible

    Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible od Vucinic, Vladan, Jentzsch, Madlen, Schwind, Sebastian, Bach, Enrica, Leiblein, Sabine, Remane, Yvonne, Rieprecht, Susanne, Otto, Sandra, Kubasch, Anne-Sophie, Behre, Gerhard, Cross, Michael, Platzbecker, Uwe, Franke, Georg-Nikolaus

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
    Tekst
    Spremi u popis
    Spremljeno u:
  4. 4
    Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases

    Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therap... od Gerhardt, Kristin, Jentzsch, Madlen, Georgi, Thomas, Sretenović, Aleksandra, Cross, Michael, Bach, Enrica, Monecke, Astrid, Leiblein, Sabine, Hoffmann, Sandra, Todorović, Milena, Bila, Jelena, Sabri, Osama, Schwind, Sebastian, Franke, Georg-Nikolaus, Platzbecker, Uwe, Vučinić, Vladan

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
    Tekst
    Spremi u popis
    Spremljeno u:
  5. 5
    Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15

    Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15 od Hell, Saskia, Jentzsch, Madlen, Franke, Georg-Nikolaus, Jäkel, Nadja, Schulze, Susann, Edelmann, Jeanett, Nenoff, Kolja, Grieb, Nora, Jeremic, Veljko, Cross, Michael, Leiblein, Sabine, Bach, Enrica, Pönisch, Wolfram, Al-Ali, Haifa-Kathrin, Schwind, Sebastian, Platzbecker, Uwe, Lange, Thoralf, Niederwieser, Dietger, Vucinic, Vladan

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
    Tekst
    Spremi u popis
    Spremljeno u:

Alati za pretragu: